PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Novel anti-malarial drug target identified

2012-07-20
(Press-News.org) An international team of scientists, led by researchers from the Department of Pediatrics at the University of California, San Diego School of Medicine, have identified the first reported inhibitors of a key enzyme involved in survival of the parasite responsible for malaria. Their findings, which may provide the basis for anti-malarial drug development, are currently published in the online version of the Journal of Medicinal Chemistry.

Tropical malaria is responsible for more than 1.2 million deaths annually. Severe forms of the disease are mainly caused by the parasite Plasmodium falciparum, transmitted to humans by female Anopheles mosquitoes. Malaria eradication has not been possible due to the lack of vaccines and the parasite's ability to develop resistance to most drugs.

The researchers conducted high-throughput screening of nearly 350,000 compounds in the National Institutes of Health's Molecular Libraries Small Molecule Repository (MLSMR) to identify compounds that inhibit an enzyme which plays an important role in parasite development: Plasmodium falciparum glucose-6-phosphate dehydrogenase (PfG6PD) is essential for proliferating and propagating P. falciparum.

"The enzyme G6PD catalyzes an initial step in a process that protects the malaria parasite from oxidative stress in red blood cells, creating an environment in which the parasite survives," said senior author Lars Bode, PhD, assistant professor in the UCSD Department of Pediatrics, Division of Neonatology and the Division of Gastroenterology, Hepatology and Nutrition. People with a natural deficiency in this enzyme are protected from malaria and its deadly symptoms, an observation that triggered the reported research.

The parasitic form of the enzyme (PfG6PD) is what contributes the majority of G6PD activity in infected red blood cells. Because the parasite lives in the blood of a malaria-infected person, the scientists aimed at identifying compounds that inhibit the parasitic form but not the human form of the enzyme. "We didn't want to interfere with the human form of the enzyme and risk potential side effects," Bode explained.

Scientific testing had previously been limited by a lack of recombinant PfG6PD. Team members in the lab of Katja Becker, PhD, at the Interdisciplinary Research Center at Justus-Liebig-University in Giessen, Germany produced the first complete and functional recombinant PfG6PD, and researchers led by Anthony Pinkerton, PhD, at Sanford-Burnham Medical Research Institute used it to identify the lead compound resulting from their efforts, ML276.

ML276 represents the first reported selective PfG6PD inhibitor, which stops the growth of malaria parasites in cultured red blood cells – even those parasites that developed resistance to currently available drugs. "ML276 is a very promising basis for future drug design of new anti-malarial therapeutics," said Bode.



INFORMATION:



Contributors to the study include Janina Preuss, UC San Diego, Justus-Liebig-University and Sanford-Burnham Medical Research Institute; Esther Jortzik, Stefan Rahlfs and Katja Becker, Justus-Liebig-University; Patrick Maloney, Satyamaheshwar Peddibhotla, Paul Hershberger, Eliot Sugarman, Becky Hood, Eigo Suyama, Kevin Nguyen, Stefan Vasile, Arianna Mangravita-Novo, Michael Vicchiarelli, Danielle McAnally, Layton H. Smith. Gregory P. Roth, Michael P. Hedrick, Palak Gosalia, Monika Milewski, Yujie Linda Li, Eduard Sergienko, Jena Diwan, Thomas D.Y. Chung, and Anthony B. Pinkerton, Sanford-Burnham.

The study was supported by the National Institutes of Health (1R21AI082434), the Deutsche Forschungsgemeinschaft, and an NIH Molecular Libraries grant (U54 HG005033) to the Conrad Prebys Center for Chemical Genomics at Sanford Burnham Medical Research Institute, one of the comprehensive centers of the NIH Molecular Libraries Probe Production Centers Network (MLPCN).



ELSE PRESS RELEASES FROM THIS DATE:

Blood vessel forming potential of stem cells from human placenta and umbilical cord blood

2012-07-20
Tampa, Fla. (July 19, 2012) – A study comparing whether endothelial colony-forming cells (ECFCs) derived from human placenta or those derived from human umbilical cord blood are more proliferative and better for forming new blood vessels has found that ECFCs derived from human placenta are more vasculogenic. The study, carried out by researchers at the Indiana School of Medicine, is published in a recent issue of Cell Medicine [2(3)] and is freely available on-line at: http://www.ingentaconnect.com/content/cog/cm. "Circulating ECFCs isolated from umbilical cord blood ...

Being in awe can expand time and enhance well-being

2012-07-20
It doesn't matter what we've experienced – whether it's the breathtaking scope of the Grand Canyon, the ethereal beauty of the Aurora Borealis, or the exhilarating view from the top of the Eiffel Tower – at some point in our lives we've all had the feeling of being in a complete and overwhelming sense of awe. Awe seems to be a universal emotion, but it has been largely neglected by scientists—until now. Psychological scientists Melanie Rudd and Jennifer Aaker of Stanford University Graduate School of Business and Kathleen Vohs of the University of Minnesota Carlson ...

Colorful science sheds light on solar heating

2012-07-20
A crucial, and often underappreciated, facet of science lies in deciding how to turn the raw numbers of data into useful, understandable information – often through graphs and images. Such visualization techniques are needed for everything from making a map of planetary orbits based on nightly measurements of where they are in the sky to colorizing normally invisible light such as X-rays to produce "images" of the sun. More information, of course, requires more complex visualizations and occasionally such images are not just informative, but beautiful too. Such is the ...

IRVE-3 flight hardware test sounding rocket

2012-07-20
NASA will launch an inflatable aeroshell/heat shield technology demonstrator on a Black Brant XI sounding rocket July 22 from the agency's launch range at the Wallops Flight Facility in Virginia. The Inflatable Reentry Vehicle Experiment (IRVE-3) is the third in a series of suborbital flight tests of this new technology. Technicians will vacuum pack the uninflated 10-foot (3.05 meters) diameter cone of high-tech inner tubes into a 22-inch (56 centimeters) diameter sounding rocket. During the flight test an on board system will inflate the tubes -- stretching a thermal ...

Tropical Depression Khanun blankets South Korea

2012-07-20
Tropical Depression Khanun came ashore with some heavy rainfall in the morning hours (local time) on Thursday, July 19. NASA's Terra satellite captured an image of Khanun's clouds on July 19, covering all of South Korea like a blanket. The Moderate Resolution Imaging Spectroradiometer (MODIS) instrument onboard NASA's Terra satellite captured a true-color image of Tropical Depression Khanun over South Korea on July 19, 2012 at 0225 UTC, or 11:25 a.m. local time, Seoul (10:25 p.m. EDT/U.S. on July 18). The last advisory on Khanun from the Joint Typhoon Warning Center ...

Vitamin D may protect against lung function impairment and decline in smokers

2012-07-20
Vitamin D deficiency is associated with worse lung function and more rapid decline in lung function over time in smokers, suggesting that vitamin D may have a protective effect against the effects of smoking on lung function, according to a new study from researchers in Boston. "We examined the relationship between vitamin D deficiency, smoking, lung function, and the rate of lung function decline over a 20 year period in a cohort of 626 adult white men from the Normative Aging Study," said lead author Nancy E. Lange, MD, MPH, of the Channing Laboratory, Brigham and ...

CPAP treatment effective in patients with milder OSA and daytime sleepiness

2012-07-20
Continuous positive airway pressure (CPAP), well established as an effective treatment for severe obstructive sleep apnea (OSA), is also effective in patients with mild and moderately severe OSA and daytime sleepiness, according to a new study. "The evidence for the efficacy of CPAP in patients with milder OSA is limited and conflicting," said lead author Terri E. Weaver, PhD, RN, professor and dean of the University of Illinois at Chicago College of Nursing. "Our multi-site, double-blind, randomized trial, the first placebo-controlled study to use sham CPAP in sleepy ...

Rutgers study: Anxiety disorders in poor moms likely to result from poverty, not mental illness

2012-07-20
NEW BRUNSWICK, N.J. – Poor mothers are more likely to be classified as having the mental illness known as generalized anxiety disorder (GAD) because they live in poverty – not because they are suffering from a psychiatric disorder, according to Rutgers researchers. Judith C. Baer, an associate professor in the School of Social Work, and her team, in the study, "Is it Generalized Anxiety Disorder or Poverty? An Examination of Poor Mothers and Their Children," published online in Child and Adolescent Social Work, argue that although high levels of stress over long periods ...

Racially diverse suburbs growing faster than white suburbs but resegregation threatens prosperity

2012-07-20
Racially diverse suburbs are growing faster than white suburbs, but resegregation threatens their prosperity and stability, according to a study entitled, "America's Racially Diverse Suburbs: Opportunities and Challenges," released this week by the Institute on Metropolitan Opportunity at the University of Minnesota Law School. Long perceived as predominantly prosperous white enclaves, suburbs are now at the cutting edge of racial, ethnic and political change in America. The study finds the number of racially diverse suburbs, municipalities ranging from 20-60 percent ...

AbetterlifeThailand.com Helps People on a Budget Live an Affluent Lifestyle in Thailand

2012-07-20
As more people struggle to afford food, housing, transportation and medical care, one company has introduced a unique solution for the rising cost of living in America. The founders of A Better Life announced today the release of its initial website, http://www.abetterlifeThailand.com, aimed at people wanting to live a better life, by helping them relocate to exotic Thailand. Entrepreneurs David Yow and Gary Orman saw a need in the marketplace for a turnkey solution where they help people to visit or relocate to Thailand because of its luxurious yet affordable lifestyle, ...

LAST 30 PRESS RELEASES:

Are lifetimes of big appliances really shrinking?

Pink skies

Monkeys are world’s best yodellers - new research

Key differences between visual- and memory-led Alzheimer’s discovered

% weight loss targets in obesity management – is this the wrong objective?

An app can change how you see yourself at work

NYC speed cameras take six months to change driver behavior, effects vary by neighborhood, new study reveals

New research shows that propaganda is on the rise in China

Even the richest Americans face shorter lifespans than their European counterparts, study finds

Novel genes linked to rare childhood diarrhea

New computer model reveals how Bronze Age Scandinavians could have crossed the sea

Novel point-of-care technology delivers accurate HIV results in minutes

Researchers reveal key brain differences to explain why Ritalin helps improve focus in some more than others

Study finds nearly five-fold increase in hospitalizations for common cause of stroke

Study reveals how alcohol abuse damages cognition

Medicinal cannabis is linked to long-term benefits in health-related quality of life

Microplastics detected in cat placentas and fetuses during early pregnancy

Ancient amphibians as big as alligators died in mass mortality event in Triassic Wyoming

Scientists uncover the first clear evidence of air sacs in the fossilized bones of alvarezsaurian dinosaurs: the "hollow bones" which help modern day birds to fly

Alcohol makes male flies sexy

TB patients globally often incur "catastrophic costs" of up to $11,329 USD, despite many countries offering free treatment, with predominant drivers of cost being hospitalization and loss of income

Study links teen girls’ screen time to sleep disruptions and depression

Scientists unveil starfish-inspired wearable tech for heart monitoring

Footprints reveal prehistoric Scottish lagoons were stomping grounds for giant Jurassic dinosaurs

AI effectively predicts dementia risk in American Indian/Alaska Native elders

First guideline on newborn screening for cystic fibrosis calls for changes in practice to improve outcomes

Existing international law can help secure peace and security in outer space, study shows

Pinning down the process of West Nile virus transmission

UTA-backed research tackles health challenges across ages

In pancreatic cancer, a race against time

[Press-News.org] Novel anti-malarial drug target identified